Funder: Dept. of the Army -- USAMRAA
Due Dates: June 6, 2025 (Pre-application) | August 27, 2025 (Full application, by invitation)
Funding Amounts: Up to $2,000,000 total costs per award over 3 years; approx. $10.5M available for ~5 awards.
Summary: Supports empirical, product-driven preclinical to IND-enabling ALS therapeutic development, requiring proof-of-concept and biomarker integration.
Key Information: Clinical trials are not permitted; lead compounds and preclinical efficacy data are required at application.